Bavarian Nordic's headquarters are located in Kvistgård,
Denmark. The site houses the company's administration, production
facility, quality control and quality assurance.
The facility is designed, built and qualified to manufacture
IMVAMUNE® and MVA-BN® recombinant vaccines.
IMVAMUNE® is classified as a BioSafety Level-1 (BSL-1)
vaccine, but Bavarian Nordic has also implemented additional
requirements through the design and layout of the facility so that
it meets the more stringent BSL-2 rules.
View Bavarian Nordic in a larger map